Lynx1 Capital Management LP

CIK

1910456

Location

DORADO, PR

Portfolio Value

Small $632,594,991

Diversification

Moderately concentrated

Filing Date

Global Rank

#2,301 / 8,622 ▲ 380 · as of Mar 2026

Top Industry

Biotechnology 100.0%

3Y Alpha vs SPY

+41.3%

Period ended 4 months ago

Filed May 18, 2026 · 2mo

18 quarters · since Dec 2021

Clone Performance

Jul 2023–Jul 2026 · vs SPY

Hypothetical growth of buying every stock this filer reported holding, rebalancing on each filing and indexed to the same start. Option positions cannot be bought this way and are left out.

Cloned portfolio

+311.1%

SPY

+67.9%

Annualised alpha

+41.3%

Max drawdown

−65.0%

Estimate. 13F holdings are quarter-lagged, so the clone rebalances about 45 days after each period end — when the filing becomes public — and it excludes option and short positions. It tracks 100% of reported value on average across 13 quarters. Past performance does not predict future results.

Portfolio Concentration

22 tracked positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025

Top Position

24.5%

−10.2 pts

Top 5

88.2%

−0.6 pts

Top 10

97.1%

−0.1 pts

HHI

1,827

Moderately concentrated−506

Portfolio Trend

18 quarters · across all stocks

Sector Breakdown

As of Mar 31, 2026

Sector	% Portfolio	Value	Positions
Healthcare	100.0%	$632,594,991	22

Last Quarter's Activity

Export CSV

Mar 31, 2026 vs Dec 31, 2025

Added To

Positions the filer increased

8 positions

Ticker	Company	Δ Shares	Shares	Value
AGIO	Agios Pharmaceuticals, Inc.	+2,531,944	2,611,568	$88,349,345
KRRO	Korro Bio, Inc.	+860,381	1,538,296	$17,413,510
GHRS	GH Research PLC	+356,713	10,763,288	$151,331,829
TRDA	Entrada Therapeutics, Inc.	+160,000	211,689	$2,671,515
DNLI	Denali Therapeutics Inc.	+141,553	1,880,303	$36,101,817
DSGN	Design Therapeutics, Inc.	+50,000	119,516	$1,271,650
HOWL	Werewolf Therapeutics, Inc.	+1,860	657,786	$547,935
NEUP	Neuphoria Therapeutics Inc.	+100	875,328	$3,562,584
No positions match the current search.

Trimmed

Positions the filer reduced

5 positions

Ticker	Company	Δ Shares	Shares	Value
IMTX	Immatics N.V.	−704,977	216,973	$2,135,014
STOK	Stoke Therapeutics, Inc.	−641,001	4,763,673	$155,105,192
XNCR	Xencor Inc	−169,160	536,398	$6,468,959
CCCC	C4 Therapeutics, Inc.	−99,231	6,998,902	$18,407,112
DTIL	Precision Biosciences Inc	−8,800	985,113	$5,418,121
No positions match the current search.

New Positions

Positions the filer opened this quarter

4 positions

Ticker	Company	Shares	Value
VYNE	VYNE Therapeutics Inc.	1,628,700	$973,962
IBIO	iBio, Inc.	68,076	$129,344
ABSI	Absci Corp	21,245	$63,735
TRAW	Traws Pharma, Inc.	15,078	$27,592
No positions match the current search.

Sold Out

Positions the filer fully exited

2 positions

Ticker	Company	Shares	Value
ARWR	Arrowhead Pharmaceuticals, Inc.	12,043	$799,534
MPLT	MapLight Therapeutics, Inc.	13,477	$236,723
No positions match the current search.

Portfolio Positions

Compact Export CSV View 13F filing

22 tracked positions · $632,594,991 total · as of Mar 31, 2026

All sectors Healthcare

Ticker	Company	Type	Shares	Δ Shares	Value (USD)	% Δ Value	% of Portfolio
STOK	Stoke Therapeutics, Inc. Healthcare	Reduced	4,763,673	-641,001	$155,105,192	−9.6%	24.52%
GHRS	GH Research PLC Healthcare	Added	10,763,288	+356,713	$151,331,829	+14.5%	23.92%
CGEM	Cullinan Therapeutics, Inc. Healthcare	Held	8,963,500	0	$127,371,335	+37.3%	20.13%
AGIO	Agios Pharmaceuticals, Inc. Healthcare	Added	2,611,568	+2,531,944	$88,349,345	+3976.3%	13.97%
DNLI	Denali Therapeutics Inc. Healthcare	Added	1,880,303	+141,553	$36,101,817	+25.8%	5.71%
CCCC	C4 Therapeutics, Inc. Healthcare	Reduced	6,998,902	-99,231	$18,407,112	+35.8%	2.91%
KRRO	Korro Bio, Inc. Healthcare	Added	1,538,296	+860,381	$17,413,510	+220.7%	2.75%
TCRX	TScan Therapeutics, Inc. Healthcare	Held	8,019,148	0	$8,099,339	+1.0%	1.28%
XNCR	Xencor Inc Healthcare	Reduced	536,398	-169,160	$6,468,959	−40.1%	1.02%
DTIL	Precision Biosciences Inc Healthcare	Reduced	985,113	-8,800	$5,418,121	+31.0%	0.86%
PASG	Passage BIO, Inc. Healthcare	Held	623,704	0	$4,896,076	−33.5%	0.77%
NEUP	Neuphoria Therapeutics Inc. Healthcare	Added	875,328	+100	$3,562,584	+4.9%	0.56%
TRDA	Entrada Therapeutics, Inc. Healthcare	Added	211,689	+160,000	$2,671,515	+402.8%	0.42%
CGON	CG Oncology, Inc. Healthcare	Held	31,591	0	$2,138,078	+63.0%	0.34%
IMTX	Immatics N.V. Healthcare	Reduced	216,973	-704,977	$2,135,014	−77.9%	0.34%
DSGN	Design Therapeutics, Inc. Healthcare	Added	119,516	+50,000	$1,271,650	+95.0%	0.20%
VYNE	VYNE Therapeutics Inc. Healthcare	NEW	1,628,700	NEW	$973,962	NEW	0.15%
HOWL	Werewolf Therapeutics, Inc. Healthcare	Added	657,786	+1,860	$547,935	+31.8%	0.09%
IBIO	iBio, Inc. Healthcare	NEW	68,076	NEW	$129,344	NEW	0.02%
PRQR	ProQR Therapeutics N.V. Healthcare	Held	68,486	0	$110,947	−19.8%	0.02%
ABSI	Absci Corp Healthcare	NEW	21,245	NEW	$63,735	NEW	0.01%
TRAW	Traws Pharma, Inc. Healthcare	NEW	15,078	NEW	$27,592	NEW	0.00%

Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.